Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kaiser

Showing results (171-180 of 206) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple MyelomaMartin F Kaiser, Andrew Hall, Katrina Walker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2019
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trialS Stintzing, P Wirapati, H-J Lenz, et al.
Genes, Chromosomes & Cancer|October 8, 2014
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myelomaEileen M Boyle, Paula Z Proszek, Martin F Kaiser, et al.
Blood|August 20, 2025
Challenging the Concept of Functional High-Risk Myeloma through Transcriptional and Genetic ProfilingSina Alexandra Beer, David A Cairns, Charlotte Pawlyn, et al.
Oncogene|January 11, 2019
The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitationKatarzyna Parzych, Paula Saavedra-García, Gabriel N Valbuena, et al.
Cancer Cell|November 16, 2010
Hdac3 is essential for the maintenance of chromatin structure and genome stabilitySrividya Bhaskara, Sarah K Knutson, Guochun Jiang, et al.
Blood|November 18, 2018
The genomic landscape of plasma cells in systemic light chain amyloidosisEileen M Boyle, Cody Ashby, Christopher P Wardell, et al.
Blood|March 26, 2015
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemiaAndrea Kühnl, Peter J M Valk, Mathijs A Sanders, et al.
Leukemia|December 2, 2020
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trialJames Croft, Sidra Ellis, Amy L Sherborne, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the 'burden of therapy' methodM Haas, D T Waldschmidt, M Stahl, et al.
Pageof 21

Showing results (171-180 of 206) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple MyelomaMartin F Kaiser, Andrew Hall, Katrina Walker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2019
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trialS Stintzing, P Wirapati, H-J Lenz, et al.
Genes, Chromosomes & Cancer|October 8, 2014
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myelomaEileen M Boyle, Paula Z Proszek, Martin F Kaiser, et al.
Blood|August 20, 2025
Challenging the Concept of Functional High-Risk Myeloma through Transcriptional and Genetic ProfilingSina Alexandra Beer, David A Cairns, Charlotte Pawlyn, et al.
Oncogene|January 11, 2019
The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitationKatarzyna Parzych, Paula Saavedra-García, Gabriel N Valbuena, et al.
Cancer Cell|November 16, 2010
Hdac3 is essential for the maintenance of chromatin structure and genome stabilitySrividya Bhaskara, Sarah K Knutson, Guochun Jiang, et al.
Blood|November 18, 2018
The genomic landscape of plasma cells in systemic light chain amyloidosisEileen M Boyle, Cody Ashby, Christopher P Wardell, et al.
Blood|March 26, 2015
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemiaAndrea Kühnl, Peter J M Valk, Mathijs A Sanders, et al.
Leukemia|December 2, 2020
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trialJames Croft, Sidra Ellis, Amy L Sherborne, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the 'burden of therapy' methodM Haas, D T Waldschmidt, M Stahl, et al.
Pageof 21